Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'

Eur Neuropsychopharmacol. 2006 Aug;16(6):437-45. doi: 10.1016/j.euroneuro.2005.11.012. Epub 2006 Jan 18.

Abstract

The role of D(1)-like [D(1), D(5)] and D(2)-like [D(2), D(3), D(4)] dopamine receptors and dopamine transduction via DARPP-32 in topographies of orofacial movement was assessed in restrained mice with congenic D(4) vs. D(5) receptor vs. DARPP-32 'knockout'. D(4) and DARPP-32 mutants evidenced no material phenotype; also, there were no alterations in topographical responsivity to either the selective D(2)-like agonist RU 24213 or the selective D(1)-like agonist SK and F 83959. In contrast, D(5) mutants evidenced an increase in spontaneous vertical jaw movements, which habituated more slowly than in wildtypes, and a decrease in horizontal jaw movements; topographical responsivity to SK and F 83959 and RU 24213 was unaltered. D(5) receptors regulate distinct topographies of vertical and horizontal jaw movement in an opposite manner. In assuming that the well-recognised role of the D(1)-like family in regulating orofacial movements involves primarily D(1) receptors, a role for their D(5) counterparts may have been overlooked.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / analogs & derivatives
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Animals
  • Chromans / pharmacology
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / deficiency
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / genetics*
  • Dyskinesia, Drug-Induced / genetics*
  • Dyskinesia, Drug-Induced / physiopathology
  • Mice
  • Mice, Congenic
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptors, Dopamine D4 / agonists
  • Receptors, Dopamine D4 / deficiency
  • Receptors, Dopamine D4 / genetics*
  • Receptors, Dopamine D5 / agonists
  • Receptors, Dopamine D5 / deficiency
  • Receptors, Dopamine D5 / genetics*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics*

Substances

  • Chromans
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Drd4 protein, mouse
  • Ppp1r1b protein, mouse
  • Receptors, Dopamine D4
  • Receptors, Dopamine D5
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • SK&F 83959
  • A 68930